These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 25762429)

  • 1. Motivation and Contingency Management Treatments for Substance Use Disorders.
    Walter KN; Petry NM
    Curr Top Behav Neurosci; 2016; 27():569-81. PubMed ID: 25762429
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Contingency management: utility in the treatment of drug abuse disorders.
    Stitzer ML; Vandrey R
    Clin Pharmacol Ther; 2008 Apr; 83(4):644-7. PubMed ID: 18305456
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A meta-analytic review of psychosocial interventions for substance use disorders.
    Dutra L; Stathopoulou G; Basden SL; Leyro TM; Powers MB; Otto MW
    Am J Psychiatry; 2008 Feb; 165(2):179-87. PubMed ID: 18198270
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Contingency Management: Using Incentives to Improve Outcomes for Adolescent Substance Use Disorders.
    Stanger C; Budney AJ
    Pediatr Clin North Am; 2019 Dec; 66(6):1183-1192. PubMed ID: 31679606
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Contingency management treatments.
    Petry NM
    Br J Psychiatry; 2006 Aug; 189():97-8. PubMed ID: 16880476
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Follow-up treatment effects of contingency management and motivational interviewing on substance use: A meta-analysis.
    Sayegh CS; Huey SJ; Zara EJ; Jhaveri K
    Psychol Addict Behav; 2017 Jun; 31(4):403-414. PubMed ID: 28437121
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of prize-based incentives on outcomes in stimulant abusers in outpatient psychosocial treatment programs: a national drug abuse treatment clinical trials network study.
    Petry NM; Peirce JM; Stitzer ML; Blaine J; Roll JM; Cohen A; Obert J; Killeen T; Saladin ME; Cowell M; Kirby KC; Sterling R; Royer-Malvestuto C; Hamilton J; Booth RE; Macdonald M; Liebert M; Rader L; Burns R; DiMaria J; Copersino M; Stabile PQ; Kolodner K; Li R
    Arch Gen Psychiatry; 2005 Oct; 62(10):1148-56. PubMed ID: 16203960
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthetic cannabinoids to avoid urine drug screens: Implications for contingency management and other treatments for drug dependence.
    Ninnemann AL; Lechner WV; Borges A; Lejuez CW
    Addict Behav; 2016 Dec; 63():72-3. PubMed ID: 27424166
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Counselor Attitudes Toward Contingency Management for Substance Use Disorder: Effectiveness, Acceptability, and Endorsement of Incentives for Treatment Attendance and Abstinence.
    Aletraris L; Shelton JS; Roman PM
    J Subst Abuse Treat; 2015 Oct; 57():41-8. PubMed ID: 26001821
    [TBL] [Abstract][Full Text] [Related]  

  • 10. How patient navigators view the use of financial incentives to influence study involvement, substance use, and HIV treatment.
    Mitchell SG; Monico LB; Stitzer M; Matheson T; Sorensen JL; Feaster DJ; Schwartz RP; Metsch L
    J Subst Abuse Treat; 2018 Nov; 94():18-23. PubMed ID: 30243412
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinician-delivered contingency management increases engagement and attendance in drug and alcohol treatment.
    Fitzsimons H; Tuten M; Borsuk C; Lookatch S; Hanks L
    Drug Alcohol Depend; 2015 Jul; 152():62-7. PubMed ID: 25982007
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Does contingency management affect motivation to change substance use?
    Ledgerwood DM; Petry NM
    Drug Alcohol Depend; 2006 Jun; 83(1):65-72. PubMed ID: 16310974
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Examining implementation of contingency management in real-world settings.
    Rash CJ; Alessi SM; Zajac K
    Psychol Addict Behav; 2020 Feb; 34(1):89-98. PubMed ID: 31343197
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Substance Abuse Treatment Patients in Housing Programs Respond to Contingency Management Interventions.
    Rash CJ; Alessi SM; Petry NM
    J Subst Abuse Treat; 2017 Jan; 72():97-102. PubMed ID: 27492676
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A review of the literature on contingency management in the treatment of substance use disorders, 2009-2014.
    Davis DR; Kurti AN; Skelly JM; Redner R; White TJ; Higgins ST
    Prev Med; 2016 Nov; 92():36-46. PubMed ID: 27514250
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Contingency Management Abstinence Incentives: Cost and Implications for Treatment Tailoring.
    Cunningham C; Stitzer M; Campbell AN; Pavlicova M; Hu MC; Nunes EV
    J Subst Abuse Treat; 2017 Jan; 72():134-139. PubMed ID: 26482136
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Contingency management treatment for substance use disorders: How far has it come, and where does it need to go?
    Petry NM; Alessi SM; Olmstead TA; Rash CJ; Zajac K
    Psychol Addict Behav; 2017 Dec; 31(8):897-906. PubMed ID: 28639812
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contingency management interventions for HIV-related behaviors.
    Haug NA; Sorensen JL
    Curr HIV/AIDS Rep; 2006 Nov; 3(4):154-9. PubMed ID: 17032574
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Contingency management for substance use disorders in Spain: Implications for research and practice.
    Secades-Villa R; García-Rodríguez O; Fernández-Hermida JR
    Prev Med; 2015 Nov; 80():82-8. PubMed ID: 26164071
    [TBL] [Abstract][Full Text] [Related]  

  • 20. "I's" on the prize: A systematic review of individual differences in Contingency Management treatment response.
    Forster SE; DePhilippis D; Forman SD
    J Subst Abuse Treat; 2019 May; 100():64-83. PubMed ID: 30898330
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.